Ignite Creation Date:
2024-05-06 @ 7:41 AM
Last Modification Date:
2024-10-26 @ 11:50 AM
Study NCT ID:
NCT02572284
Status:
COMPLETED
Last Update Posted:
2023-01-19
First Post:
2015-10-07
Brief Title:
Dose Escalation Study of Preoperative SBRT for High Risk Prostate Cancer
Sponsor:
H Lee Moffitt Cancer Center and Research Institute
Organization:
H Lee Moffitt Cancer Center and Research Institute
Study Overview
Official Title:
A Phase I Dose Escalation Study of Preoperative Stereotactic Body Radiation Therapy SBRT for High Risk Prostate Cancer
Status:
COMPLETED
Status Verified Date:
2023-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to compare the effects good andor bad of different doses of SBRT given before prostatectomy Depending when participants enter the study they will be treated with either 5 or 6 gray Gy per day of radiation A Gy is a measure of radiation dose The standard dose is 10Gy per day when SBRT is the only treatment to the prostate and no surgery is planned The researchers want to see which dose of radiation will work best with the least amount of side effects About 4-6 weeks after SBRT participants will have a prostatectomy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None